FRATTAROLI JOSEPH 4
4 · Inhibikase Therapeutics, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
FRATTAROLI JOSEPH
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-05-19$0.64/sh+3,948$2,543→ 48,091 total
4 · Inhibikase Therapeutics, Inc. · Filed May 23, 2022
Common Stock